Back

Prognostic significance of the invasive assessment of coronary microvascular dysfunction: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Imaging and physiology in coronary intervention Invasive Imaging and Functional Assessment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kyriakos Dimitriadis

Hippokration General Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Discussant - Imaging and physiology in coronary intervention
Presentation thumbnail
Predictors of stent underexpansion for severely calcified lesions after debulking
Doctor M. Nishino (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
Catheter selection in patients with anomalous coronary arteries using coronary computed tomography angiography
Doctor F. Beerkens (New York City, US)
Abstract
Presentation thumbnail
The physiological severity and distribution of coronary artery disease are key decision factors in stable coronary artery disease: results of the COMMIT-LAD retrospective registry
Doctor R. Bova (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Arrhythmia prevention protocol during papaverine administration for invasive coronary functional assessment
Doctor D. Vassilev (Ruse, BG)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Imaging and physiology in coronary intervention

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Invasive assessment of coronary microvascular dysfunction and its association with clinical outcomes in patients with acute coronary syndrome: a meta-analysis
thumbnail
Congress Session
Comprehensive diagnosis and treatment of coronary microvascular dysfunction in patients with chronic coronary syndromes
thumbnail
Congress Presentation
Association between peripheral microangiopathy and coronary microvascular dysfunction in patients with ischemia and non-obstructive coronary arteries

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources